Carisma Therapeutics Inc. (CARM)
0.40
-0.00 (-0.25%)
At close: Mar 03, 2025, 3:59 PM
0.42
3.94%
After-hours: Mar 03, 2025, 05:30 PM EST
Carisma Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 77.61M | 24.19M | 28.55M | 51.79M | 48.12M | 50.42M | 14.68M | 25.34M | 36.08M | 54.06M | 7.94M | 7.88M | 700K |
| Short-Term Investments | n/a | 27.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | 30K | 20K | 20K | 20K | 20K | 10K | 10K | 94K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 146K | 4.11M | -84.93M | -78.5M | 196K | 20K | 120K | 10K | 13K | 113K | 2.45M | 35K | 141K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | -825K | -24.49M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 2.87M | 2.6M | 1.24M | 1.28M | 6.33M | 1.33M | 301K | 585K | 232K | 342K | 88K | 389K | 289K |
| Total Current Assets | 80.47M | 54.59M | 29.79M | 53.06M | 54.45M | 51.76M | 14.98M | 25.93M | 36.31M | 54.4M | 8.03M | 8.27M | 989K |
| Property-Plant & Equipment | 8.94M | 13.45M | 5.66M | 5.19M | 238K | 321K | 522K | 796K | 407K | 486K | 759K | 1.2M | 1.53M |
| Goodwill & Intangibles | n/a | -82.48M | 13.06M | 13.06M | 59.46M | 59.46M | 59.46M | 77.36M | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 9.08M | 17.56M | 5.66M | 5.4M | 59.92M | 59.8M | 60.12M | 78.17M | 514K | 599K | 3.21M | 1.23M | 1.68M |
| Total Assets | 89.55M | 72.15M | 35.45M | 58.46M | 114.36M | 111.56M | 75.1M | 104.1M | 36.83M | 55M | 11.24M | 9.5M | 2.67M |
| Account Payables | 3.93M | 1.73M | 2.32M | 3.29M | 1.9M | 1.37M | 907K | 1.67M | 1.25M | 2.46M | 1.75M | n/a | n/a |
| Deferred Revenue | 1.41M | 2.46M | n/a | 1.5M | n/a | n/a | n/a | 425K | 406K | 506K | 1.11M | n/a | n/a |
| Short-Term Debt | 1.94M | 4.6M | 898K | 813K | n/a | n/a | n/a | n/a | 4.13M | 251K | 1.64M | n/a | 610K |
| Other Current Liabilities | 8.63M | 10.88M | 4.47M | 1.57M | 6.62M | 4.75M | 3.81M | 1.89M | 1.79M | 1.99M | 850K | 1.72M | 1.52M |
| Total Current Liabilities | 15.91M | 19.67M | 7.69M | 5.68M | 8.52M | 6.11M | 4.72M | 3.98M | 7.58M | 5.2M | 5.35M | 1.82M | 2.22M |
| Long-Term Debt | 1.19M | 35.56M | 1.73M | 2.63M | n/a | n/a | n/a | n/a | 9.76M | 9.75M | 2.88M | 1.77M | 419K |
| Other Long-Term Liabilities | 926K | 1.04M | n/a | n/a | 120.02M | 48.71M | 39.81M | 45.1M | 538K | 3.22M | 677K | 170K | 175K |
| Total Long-Term Liabilities | 47.11M | 81.61M | 1.73M | 2.63M | 132.55M | 61.24M | 52.34M | 61.44M | 10.3M | 12.97M | 3.54M | 1.94M | 594K |
| Total Liabilities | 63.02M | 101.28M | 9.43M | 8.31M | 141.06M | 67.35M | 57.06M | 65.42M | 17.88M | 18.17M | 8.89M | 3.76M | 2.81M |
| Total Debt | 3.12M | 40.16M | 2.63M | 3.44M | n/a | n/a | n/a | n/a | 13.9M | 10M | 4.52M | 2M | 1.03M |
| Common Stock | 40K | 2K | 199K | 140K | 107K | 77K | 35K | 25K | 20K | 18K | 2K | 1K | 1K |
| Retained Earnings | -245.1M | -158.22M | -97M | -56.21M | -293.52M | -186.02M | -152.33M | -123.31M | -125.2M | -91.75M | -57.59M | -39.57M | -19.91M |
| Comprehensive Income | n/a | -41K | -199K | -140K | -758K | -539K | -331K | -71K | -1.96M | -1.75M | -1.34M | -899K | -451K |
| Shareholders Equity | 26.53M | -49.26M | 11.63M | 35.76M | -26.7M | 44.21M | 18.03M | 38.68M | 18.94M | 36.83M | 2.35M | 5.74M | -147K |
| Total Investments | n/a | 27.8M | 20K | 20K | 20K | 20K | 10K | 10K | 94K | n/a | n/a | n/a | n/a |